International Journal of the Cardiovascular Academy (Sep 2023)

Endovascular Revascularization of Lower Extremity Arteries: A Single-center Retrospective Report on Long Lesions (>100 mm)

  • İbrahim Çağrı Kaya,
  • Halil Bulut,
  • Merih Özbayburtlu,
  • Alper Selim Kocaoğlu

DOI
https://doi.org/10.4274/ijca.2023.32032
Journal volume & issue
Vol. 9, no. 3
pp. 60 – 65

Abstract

Read online

Background and Aim:Lower extremity peripheral artery disease (PAD) is a prevalent condition characterized by the accumulation of plaque in the arteries of the lower extremities. Traditionally, open surgery has been the conventional method for managing complex lesions in these patients. However, there is a growing trend toward using endovascular therapy as the preferred approach. This study aimed to assess the feasibility and effectiveness of endovascular revascularization in patients with a lower extremity PAD, specifically those with long lesions exceeding 100 mm. By focusing on this subgroup, the study sought to provide insights into the potential benefits of endovascular treatment for this particular patient population.Materials and Methods:This retrospective cohort study included 41 patients with long lesions who underwent endovascular revascularization. The study received ethical approval and patient data were collected and analyzed. Statistical analyzes were conducted to summarize the data.Results:In the analyzed cohort, the study reported that most patients undergoing PAD treatment was males. The average age of the patients was 62.4 years. The prevalence of common comorbidities was as follows: coronary artery disease in 43.9% of patients, hypertension in 43.9%, type 2 diabetes mellitus in 41.5%, and tobacco use in 51.2%. Medication usage included aspirin (97.6% of patients), clopidogrel (82.9%), angiotensin-converting enzyme inhibitors (29.3%), cilostazol (29.3%), statins (36.6%), insulin (24.4%), and oral antidiabetics (17.1%). Lesion characteristics revealed that 41.5% of patients had complete occlusion, while most procedures involved drug-coated balloons (90.2%). Complications were reported in a small percentage of cases (9.8%). Revascularization outcomes showed high rates of technical success (87.8%) and hemodynamic success (97.8%), with favorable primary patency rates at both 30-day (97.8%) and 6-month (87.8%) follow-ups.Conclusion:This study highlights the effectiveness of endovascular treatment for long lesions in lower extremity arteries, with favorable outcomes in terms of primary patency and hemodynamic success.

Keywords